Antidotes for patients taking novel oral anti-coagulants.
نویسندگان
چکیده
منابع مشابه
The Role of Novel Oral Anti-Coagulants in Stroke Prevention in Non-Valvualr Atrial Fibrillation
Atrial Fibrillation (AF) is the most common dysrhythmia seen in primary care. Thromboembolic stroke remains one of the most feared complications of this rhythm disturbance. Five landmark trials have demonstrated the efficacy of warfarin and aspirin in reducing this risk. Warfarin use is known to be labor intensive for patients and concerns regarding multiple drug interactions and bleed risk hav...
متن کاملA new paradigm shift in antithrombotic therapy
Decades after the introduction of oral anti-coagulants namely the vitamin K antagonist (VKA) Warfarin and antiplatelet agents such as Aspirin and Plavix, new classes of direct, small molecule, novel oral anti-coagulant medications and antiplatelet P2Y12 receptor inhibitors have recently become available. For the novel oral anticoagulants (NOAC), these agents can be separated by direct thrombin ...
متن کاملOral Manifestations of Patients Taking Anti-Hypertensive Medications
Background and Aim: High blood pressure is a common cardiovascular disease. Most cardiovascular medications have adverse oral side effects. This study aimed to determine the prevalence of oral manifestations associated with the intake of anti-hypertensive medications. Materials and Methods: This cross-sectional analytical study examined 142 patients with a history of hypertension referred to D...
متن کاملUpdate on anti-coagulation in atrial fibrillation
Atrial fibrillation (AF), the most common clinically relevant arrhythmia, affects 2.2 million individuals in the USA and 4.5 million in Europe, resulting in significant morbidity and mortality. Pharmacotherapy aimed at controlling both heart rate and rhythm is employed to relieve AF symptoms, though debate continues about which approach is preferable. AF prevalence rises with age from 0.4% to 1...
متن کاملOral anticoagulation pdf
New oral anticoagulants: a practical guide on prescription, laboratory. The prescription of new oral anticoagulants NOAC. Label2012202155s000lbl.pdf.Oral anticoagulants OACs are used for the prevention of embolus in atrial. Www.sspcrs.ielibrhtmlOralAnticoagulantIndividualReimbursemenApplication.pdf.oral anticoagulants Baglin Rose, 1998 Baglin et al, 2006. Anticoagulation control but results in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- World journal of emergency medicine
دوره 6 4 شماره
صفحات -
تاریخ انتشار 2015